Johnson & Johnson Given Consensus Rating of “Hold” by Brokerages (NYSE:JNJ)
Shares of Johnson & Johnson (NYSE:JNJ) have received a consensus recommendation of “Hold” from the seventeen analysts that are presently covering the stock, Stock Ratings Network reports. One equities research analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation and six have given a buy recommendation to the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $98.00.
Several analysts have recently commented on the stock. Analysts at Jefferies Group reiterated a “hold” rating on shares of Johnson & Johnson in a research note on Monday, August 11th. They now have a $108.00 price target on the stock, down previously from $114.00. Separately, analysts at Citigroup Inc. reiterated a “buy” rating on shares of Johnson & Johnson in a research note on Wednesday, July 16th. They now have a $122.00 price target on the stock, up previously from $117.00. Finally, analysts at Deutsche Bank reiterated a “hold” rating on shares of Johnson & Johnson in a research note on Wednesday, July 16th. They now have a $107.00 price target on the stock, up previously from $102.00.
Johnson & Johnson (NYSE:JNJ) opened at 101.17 on Thursday. Johnson & Johnson has a one year low of $85.50 and a one year high of $106.74. The stock’s 50-day moving average is $102.6 and its 200-day moving average is $98.70. The company has a market cap of $285.3 billion and a P/E ratio of 18.86.
Johnson & Johnson (NYSE:JNJ) last posted its quarterly earnings results on Tuesday, July 15th. The company reported $1.66 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.54 by $0.12. The company had revenue of $19.50 billion for the quarter, compared to the consensus estimate of $18.86 billion. During the same quarter last year, the company posted $1.48 earnings per share. Johnson & Johnson’s revenue was up 9.1% compared to the same quarter last year. Analysts expect that Johnson & Johnson will post $5.92 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Tuesday, September 9th. Stockholders of record on Tuesday, August 26th will be given a dividend of $0.70 per share. This represents a $2.80 dividend on an annualized basis and a yield of 2.77%. The ex-dividend date of this dividend is Friday, August 22nd.
Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a broad range of products in the health care field.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.